Midterm Flashcards

(41 cards)

1
Q

Risk factors for PAD:

A

ncreasing age, sex (Males>Females), DM, smoking, HTN, hyperlipidemia, hypertriglyceridemia, and hyperhomocystinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ABI > 1.10

A

normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ABI 0.5-1.0

A

claudication

pain in calf with ambulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ABI 0.2-0.5

A

critical limb ischemia
atrophic changes
rest pain
wounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ABI < 0.2

A

severe ischemia
gangrene
severe necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Absolute stop test indicators for exercise stress test

A
Drop in SBP>10mmHg from baseline w/ ischemia
moderate to severe angina
ataxia, dizziness, presyncope
cyanosis or pallor
sustained VT
ST segment elevation
subject requests to stop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Relative stop test indicators for exercise stress test

A

Drop in SBP >10mmHg in absence of ischemia
fatigue, SOB, wheezing, leg cramps or claudication
increasing chest pain
hypertensive response (SBP>250, DBP>115)
ST or QRS changes such as ST segment depression
Arrhythmias
Development of bundle brance block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Expected ECG Changes in the Normal Heart

A

▪ RR interval decreases
▪ P-wave amplitude and morphology undergo minor changes
▪ Septal Q-wave amplitude increases
▪ R-wave height increases from rest to submaximal exercise and then reduces to a minimum at maximal exercise
▪ The QRS complex experiences minimal shortening
▪ J-point depression occurs
▪ Tall, peaked T waves occur (high interindividual variability)
▪ ST segment becomes upsloping
▪ QT interval experiences a rate-related shortening
▪ Superimposition of P waves and T waves on successive beats may be observed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypoglycemia S/S:

A
o	Tremor/shakiness/anxiety
o	Tachycardia
o	Increased sweating
o	Hunger
o	Irritability
o	Weakness
o	Dizziness
o	Numbness or tingling of mouth and face
o	Nausea/vomiting
o	Headache
o	Lethargy
o	Drowsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyperglycemia S/S

A
o	ncreased/frequent urination
o	Dry mouth/increased thirst
o	Weakness or fatigue
o	Hunger
o	Flu-like achiness
o	HA
o	Facial flushing
o	Nausea or vomiting
o	Fruity breath
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ketoacidosis S/S

A
▪	Facial flushing
▪	Dry skin
▪	N/V
▪	Abdominal pain
▪	Deep, rapid breathing
▪	Fruity smelling breath
▪	Coma Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

R ventricular failure S/S

A
  • Dependent edema
  • JVD
  • Weight gain
  • Liver engorgement, abdominal pain
  • Ascites
  • Anorexia, nausea, bloating
  • Cyanosis
  • Right sided S3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

L ventricular failure S/S

A
♣	pulmonary congestion
•	Dyspnea, dry cough
•	Orthopnea
•	Paroxysmal nocturnal dyspnea
•	Pulmonary rales, wheezing
•	s/s of acute pulmonary edema (dyspnea, pallor or cyanosis, diaphoresis, tachycardia, anxiety, agitation)
♣	low cardiac output
•	Hypotension
•	Tachycardia
•	Lightheadedness, dizziness
•	Fatigue, weakness
•	s/s of peripheral hypoperfusion (weak, thready pulse, vasoconstriction)
•	poor exercise tolerance
•	S3 and sometimes S4 (3rd heart sound or ventricular gallop, 4th heart sound or atrial gallop)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Stage A CHF:

A

at high risk for HF but w/out structural heart disease or symptoms of HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Therapy goals and drugs for stage A:

A
treat HTN
smoking cessation
regular exercise
treat lipid disorder
ACE or ARB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stage B CHF:

A

structural heart disease but without signs or symptoms of HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Therapy goals and drugs for stage B:

A

therapy same as stage A
ACE or ARB
beta-blockers in some

18
Q

Stage C CHF

A

structural heart disease with prior or current symptoms of HF
SOB, reduced exercise tolerance

19
Q

Therapy goals and drugs for stage C:

A

all measures under A and B
sodium restrictions
ACE, beta-blockers, diuretics
selected: digoxin, nitrates, ARB, aldosterone

20
Q

Stage D CHF:

A

refractory HF requiring specialized interventions

21
Q

Therapy goals and drugs for stage

A

symptoms at rest
appropriate measures for A,B,C,D
end of life care

22
Q

What levels of resting BP require referral to MD?

A

SBP> 200 or DBP> 100

23
Q

Medical clearance for PT if bp is:

A

SBP >180 & DBP > 110)

24
Q

Exercise testing should be terminated if BP:

A

SBP >250 or DBP >115

25
Orthostatic hypotension
SBP drop of >20 or DBP drop >10
26
Contraindications to low level testing
``` o Unstable angina or angina at rest o Severe heart failure (overt left ventricular failure on exam with pulmonary rales and S3 heart sound) o Serious arrhythmias at rest o Second or third degree heart block o Disabling musculoskeletal abnormalities o Valvular heart disease o BP > 180/105 mmHg o Pt refuses to sign consent form ```
27
• Absolute contraindications to exercise testing
o Recent MI o Acute pericarditis or myocarditis o Resting or unstable angina o Serious ventricular or rapid arterial arrhythmias o Tachycardia a-fib o Unrelated second or third degree heart block o Any acute illness
28
S3
abnormal ventricular gallop loss of ventricular compliance early diastole
29
S4
increased resistance to ventricular filling heard in hypertensive cardiac disease, CAD just before S1
30
Exercise recommendations for PAD
``` short intervals (1-5 mins), alternating with rest increase intervals and decrease rest longer warm up time for colder climates sensory exam before exercise footwear and hygiene emphasized ```
31
Hypertrophic cardiomyopathy:
diastole dysfunction risk of sudden death in athletes thickened left ventricular wall
32
Dilated cardiomyopathy
enlargement of all chambers systolic dysfunction most common
33
Restrictive cardiomyopathy:
rigid ventricular walls diastolic dysfunction least common
34
Stage I of Pulmonary edema in CHF
redistribution PCWP 13-18 cardiomegaly
35
Stage 2 of Pulmonary edema in CHF
``` interstitial edema PCWP 18025 kerley lines peribronchial cuffing hazy contour of vessels ```
36
Stage 3 of Pulmonary edema in CHF
alveolar edema PCWP>25 consolidation pleural effusion
37
Left anterior descending artery
anterior ventricular septum anterior left ventricle the apex
38
Left circumflex
left atrium left ventricular lateral wall left ventricular posterior wall
39
Sinus node
right atrium
40
Right marginal artery
right ventricle
41
Posterior descending artery
posterior ventricular septum inferior wall of left ventricle